How Rapid Novor is Responding to COVID-19
Our Commitment to Our Clients and Team Members
Rapid Novor, Inc. recognizes the importance of maintaining the health and well-being of both our clients and dedicated team members. This is why we have incorporated additional health and safety protocols. These new protocols include mobilizing our team, minimizing the number of team members working in the lab at the same time, and enforcing stricter shipping and handling procedures.
Business Operations
According to the Government of Ontario’s list of essential workplaces, Rapid Novor Inc. is considered an essential business and as such, we are able to continue our core operations.
Our Project Delivery Timelines
Through implementing innovative business and operations processes, our team continues to meet our regular project delivery timelines.
Our Commitment to Scientific Discovery
Our motto at Rapid Novor Inc. is “speed up discovery”, so despite the growing concern over what faces our industry due to minimizing research budgets and shrinking capital, we truly believe there is no time to pause discovery. This is why we have made a commitment to sequence one antibody, free of charge, for a different researcher each month during the COVID-19 period. To learn more and apply go to: novor.cloud/grant-program/
Newsletter for All Things Protein Sequencing
Breakthrough Bispecific Antibody R&D Techniques, Apr 20 11:00am EST.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics